Atlantic

Specialisation

Retina and Vitreous.

Full title

Phase IV, randomised, double-blind trial with simulated control for the analysis of the efficacy, safety and tolerability of aflibercept intravenous monotherapy compared to aflibercept and concomitant photodynamic therapy in patients with polypodal choroidal vasculopathy.

Promoter

EVICR (European Vision Institute Clinical Research).

Start date

May 2016.